Position in GRAL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,370,725
+$89,682 QoQ
Shares Held
20,078
-19.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#101
of 374 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $15,038,497 across 17 Diagnostics & Research names. GRAL ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
6,365 | $3,350,790 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,138 | $2,074,627 | |
| 3 | NTRA |
Natera, Inc.
|
6,205 | $1,684,347 | |
| 4 | VCYT |
Veracyte, Inc.
|
24,694 | $1,450,278 | |
| 5 | GRAL |
GRAIL, Inc.
This page
|
20,078 | $1,370,725 | |
| 6 | DHR |
Danaher Corp /De/
|
7,015 | $1,336,217 | |
| 7 | ILMN |
Illumina, Inc.
|
3,154 | $554,567 | |
| 8 | CDNA |
CareDx, Inc.
|
16,518 | $470,763 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,370,725 | 20,078 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,281,043 | 24,788 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,949,397 | 22,776 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $558,305 | 9,442 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $448,382 | 8,720 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $307,833 | 12,053 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $183,158 | 10,261 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||